Related Experiment Video
Updated: Jun 20, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Pharmaceutical services evaluation in Brazil: broadening the results of a WHO methodology
Isabel Cristina Martins Emmerick1, Vera Lucia Luiza, Vera Lucia Edais Pepe
1Núcleo de Assistência Farmacêutica, Departamento de Ciências Biológicas, Escola Nacional de Saúde Pública, Fundação Oswaldo Cruz, Rio de Janeiro 21041-210. icme@ensp.fiocruz.br
Abstract:
The objective of this paper is to explore and analyze the results of the Diagnosis of the Pharmaceutical Situation in Brazil (DiagAF-Br) from a regional perspective. The study made use of an exploratory approach of multiple cases based on the DiagAF-Br data collected in five Brazilian states. A descriptive analysis of selected indicators was performed in each of the Brazilian states in three pharmaceutical dimensions: access, quality, and rational use of medicines. The mainly results concerning the percentage of completed prescriptions varied from 1.1% in the State of Goiás to 98.6% in Espírito Santo; the percentage of patients who know how to take their medicines varied from 60.4% in Sergipe to 93.3% in Rio Grande do Sul. Educational level showed to be an important predictor of knowledge on how to use medicines, especially relevant when prescription is completed. The average number of prescribed medicines, approximately 2.1, did not show any difference between the visited sites. Different levels of management capacity and services organization were identified, suggesting the need for more adequate strategies to improve access, quality and mainly rational use of medicines in Brazil.
Related Concept Videos
International Nursing Organizations II
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Bioequivalence: Overview
Measurement of Bioavailability: Pharmacodynamic Methods
Analysis of Population Pharmacokinetic Data
Bioequivalence studies: Biowaivers